Seeking Alpha

More from Pfizer's (PFE +2.8%) earnings call: CEO Ian Read says the drug maker is separated into...

More from Pfizer's (PFE +2.8%) earnings call: CEO Ian Read says the drug maker is separated into two business models: one focused on patent-protected drugs and the other on off-patent drugs. Read calls them "innovative" and "value" businesses, each with separate management. He adds that the company has yet to determine whether shareholders are interested in investing in two distinct companies or not, which leaves the door open to further potential spinoffs.

Check out Seeking Alpha’s new Earnings Center »

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs